SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-14-009793
Filing Date
2014-02-13
Accepted
2014-02-13 16:47:00
Documents
1
Group Members
BARBARA N. LUBASHBRADLEY J. BOLZONBRIAN G. ATWOODCHARLES M. WARDENDONALD B. MILDERREBECCA B. ROBERTSONROSS A. JAFFESAMUEL D. COLELLAVERSANT SIDE FUND II, L.P.VERSANT VENTURE CAPITAL II, L.P.VERSANT VENTURES II, LLCWILLIAM J. LINK

Document Format Files

Seq Description Document Type Size
1 SC 13G a14-5699_5sc13g.htm SC 13G 414688
  Complete submission text file 0001104659-14-009793.txt   416803
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 14606850
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 SAND HILL ROAD BLDG. 4, STE. 210 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BLDG. 4, STE. 210 MENLO PARK CA 94025 650-233-7877
Versant Affiliates Fund II-A, LP (Filed by) CIK: 0001354132 (see all company filings)

IRS No.: 943410106 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G